About this trial
Unrestricted parental smoking habits are lifestyle risk behaviors associated with chronic, systemic inflammation, which promotes the pathogenesis of non-communicable diseases (NCDs). Exposure to secondhand tobacco smoke in early life contributes to the development of specific NCDs in children, i.e. asthma. Early preventive measures to improve lifestyle behavior in parents are therefore of utmost importance. The aim of ELIPSE-II is to assess whether an eHealth application intervention for parents is feasible and efficacious in lowering levels of urinary cotinine as a measure of second-hand smoke exposure in their children .
Eligibility criteria
Qualifiers
Age: younger than 6 years
Exposed to second-hand smoke at home (at least one parent smoking)
German speaking parent
All sex and ethnic backgrounds
Disqualifiers
Participation in another study/trial targeting similar outcomes
Participation in an active smoking cessation programme
Trial design
Treatments tested in this trial
- Life-Style app
- Sham Comparator
Treatment groups
Sponsors and collaborators
Insel Gruppe AG, University Hospital Bern
Lead sponsor
University of Bern
Collaborator